GlassScriptPhysician profile
Paul A Hatcher
NPI 1790858454
$25,635.14
in general payments reported to CMS, 2019-2025
76 companies · $8,312 in 2025
The $8,312 reported for 2025 was more than what 93% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,760 · 2020: $5,013 · 2021: $2,150 · 2022: $2,952 · 2023: $3,130 · 2024: $2,318 · 2025: $8,312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,118 · Food and Beverage: $5,882 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,158 · Consulting Fee: $500 · Education: $85.00 · Entertainment: $16.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,117.64 |
| Food and Beverage | $5,882.40 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,157.81 |
| Consulting Fee | $500.00 |
| Education | $85.00 |
| Entertainment | $16.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $7,765.76 | 2025 | |
| Amgen INC. | $3,920.69 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $1,110.86 | 2019-2024 | Xiaflex, Aveed, Edex |
| Astellas Pharma US INC | $931.10 | 2019-2025 | Xtandi, Myrbetriq |
| Boston Scientific Corporation | $846.70 | 2019-2025 | General - Erectile Dysfunction, Rezum Generator |
| Janssen Biotech, INC. | $840.12 | 2019-2025 | Erleada |
| Axonics, INC. | $834.90 | 2020-2024 | Axonics, Bulkamid |
| Pfizer INC. | $739.55 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $691.31 | 2023-2025 | Gemtesa, Orgovyx |
| Dendreon Pharmaceuticals LLC | $636.71 | 2019-2024 | Provenge |
| Cipla USA INC. | $618.36 | 2022 | |
| Myriad Genetic Laboratories, INC. | $412.55 | 2021-2025 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $402.92 | 2019-2024 | |
| Urovant Sciences INC | $399.34 | 2021-2022 | |
| Innovation Technologies INC | $332.71 | 2021-2024 | Irrisept |
Show all 76 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $284.80 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $275.39 | 2019-2022 | |
| Rochester Medical Corporation | $250.72 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $235.93 | 2019-2024 | Bard Urinary Drainage Bag |
| Myovant Sciences INC. | $226.07 | 2021-2022 | |
| Teleflex LLC | $221.18 | 2021-2024 | Urolift |
| Coloplast Corp | $217.21 | 2019-2024 | Speedicath |
| Blue Earth Diagnostics | $212.59 | 2019-2025 | Posluma |
| Abbvie INC. | $203.87 | 2019-2024 | |
| Caldera Medical, INC | $189.68 | 2021-2023 | Desara |
| Antares Pharma, INC. | $160.15 | 2019-2024 | Xyosted, Nocdurna, Tlando |
| Medtronic USA, INC. | $136.95 | 2019-2020 | |
| Smoky Mountain Surgical LLC | $134.99 | 2024 | |
| 180 Medical, INC. | $134.16 | 2021-2024 | Gentlecath |
| Profound Medical Corp. | $132.91 | 2025 | Tulsa-Pro |
| Endo USA, INC. | $132.13 | 2024-2025 | Xiaflex, Aveed |
| Verity Pharmaceuticals INC. | $126.96 | 2022-2024 | Trelstar, Tlando |
| Janssen Scientific Affairs, LLC | $124.99 | 2024 | Erleada |
| Urogen Pharma, INC. | $112.99 | 2020-2024 | Jelmyto |
| Procept Biorobotics Corporation | $106.06 | 2019 | |
| Tolmar, INC. | $105.69 | 2023-2025 | Eligard, Jatenzo |
| Comsort, INC | $100.00 | 2019 | |
| Laborie Medical Technologies Corp. | $83.87 | 2020-2025 | |
| Biotissue Holdings INC. | $83.13 | 2020 | |
| Clarus Therapeutics INC. | $71.70 | 2021 | |
| Calyxo, INC. | $71.43 | 2025 | Cvac Aspiration System |
| Cook Medical LLC | $69.56 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $69.36 | 2024 | |
| Medtronic, INC. | $58.77 | 2021-2024 | Interstim |
| Dornier Medtech America, INC | $54.15 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $54.11 | 2022-2023 | Seglentis |
| Progenics Pharmaceuticals, INC. | $49.93 | 2023 | Pylarify |
| Astrazeneca Pharmaceuticals LP | $46.78 | 2023 | |
| Merck Sharp & Dohme LLC | $41.83 | 2023 | Lynparza, Keytruda |
| Halozyme INC | $39.26 | 2023 | |
| Mallinckrodt Enterprises LLC | $38.54 | 2019 | |
| Baxter Healthcare | $35.99 | 2023-2024 | Floseal, Perclot |
| Mallinckrodt Hospital Products INC. | $33.73 | 2020 | |
| Davol INC. | $32.97 | 2021 | |
| Tempus Ai, INC | $29.20 | 2024 | Xt Cdx |
| Ferring Pharmaceuticals INC. | $25.06 | 2019 | |
| Axogen | $24.81 | 2019 | |
| Dentsply Ih Ab | $23.38 | 2025 | Lofric |
| Ambu INC. | $21.85 | 2021 | |
| Convatec INC. | $21.59 | 2023 | |
| Accord Healthcare, INC. | $20.88 | 2024 | |
| Mission Pharmacal Company | $19.69 | 2020 | |
| Integra Lifesciences Corporation | $18.73 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Bard Access Systems, INC. | $17.21 | 2019 | |
| Abc Home Medical Supply, INC. | $17.01 | 2024 | |
| Provepharm INC. | $16.96 | 2024 | Bludigo |
| Novo Nordisk INC | $16.22 | 2024 | Rivfloza |
| Aytu Biopharma, INC. | $16.18 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.88 | 2022 | |
| Hollister Incorporated | $13.99 | 2023 | Infyna Chic, Onli, Vapro |
| Olympus America INC. | $12.61 | 2022 | |
| Duchesnay USA Incorporated | $12.56 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $12.41 | 2019 | |
| Genzyme Corporation | $12.07 | 2021 | |
| Zyla Life Sciences, INC. | $11.47 | 2019 | |
| Allergan, INC. | $11.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Hatcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.